Home » Topics » Regulatory

Regulatory
RSS

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

Restenosis prevention trial of tranilast is largest ever

Feb. 7, 2000

COX-2 inhibitor now available for FAP indication

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

IND filed for nasal leuprolide as endometriosis therapy

Feb. 3, 2000

NDA filed for once-daily didanosine capsules

Feb. 2, 2000

FDA advisory committee recommends approval of Novantrone for MS indication

Feb. 1, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Beclomethasone Clickhaler approved in France

Jan. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...